SCHEMBL8614290

SCHEMBL8614290

COc1cc2nc(-c3ccccc3)cc(C(=O)O)c2cc1OC

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 2/20 0.66
DHODH Q02127 5/20 0.65
KDM4E B2RXH2 7/20 0.64
HSD17B10 Q99714 4/20 0.64
ALDH1A1 P00352 4/20 0.64
TP53 P04637 2/20 0.64
CYP1A2 P05177 2/20 0.64
CYP2C19 P33261 1/20 0.64
HIF1A Q16665 1/20 0.64
SMN1; SMN2 Q16637 4/20 0.64
LMNA P02545 3/20 0.64
CYP2D6 P10635 1/20 0.59
CYP2C9 P11712 1/20 0.59
PLA2G2A P14555 1/20 0.57
HPGD P15428 3/20 0.56
NPC1 O15118 1/20 0.56
MAPT P10636 1/20 0.56
NFKB1 P19838 1/20 0.56
RAB9A P51151 1/20 0.56
NFKB2 Q00653 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5532004 0.90 KDM4E (0.69) PDE10ADHODHKDM4EHSD17B10ALDH1A1
SCHEMBL8231325 0.89 DHODH (0.64) PDE10ADHODHKDM4EHSD17B10ALDH1A1
SCHEMBL30690053 0.89 PLA2G2A (0.73) PDE10ADHODHKDM4EHSD17B10ALDH1A1
SCHEMBL8172197 0.89 DHODH (0.61) PDE10ADHODHKDM4EHSD17B10ALDH1A1
SCHEMBL8616465 0.84 CYP2C9 (0.61) PDE10ADHODHKDM4EHSD17B10ALDH1A1
SCHEMBL10761434 0.84 NPC1 (0.54) PDE10ADHODHKDM4EHSD17B10ALDH1A1
SCHEMBL245078 0.83 PLA2G2A (0.81) PDE10ADHODHKDM4EHSD17B10ALDH1A1
SCHEMBL4189945 0.82 TACR3 (0.74) PDE10ADHODHKDM4EHSD17B10ALDH1A1
SCHEMBL8620862 0.82 ALDH1A1 (0.54) DHODHKDM4EALDH1A1TP53CYP2C19
SCHEMBL29788461 0.81 DHODH (0.81) DHODHKDM4EALDH1A1SMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0726254-B1 Quinoline-4-carbonylguanidine derivates, process for producing the same and pharmaceutical preparations containing the compounds MITSUI TOATSU CHEMICALS (JP) 1998-05-06 EP disclosed
US-5627193-A MEDICAL DIAGNOSIS, CARDIOVASCULAR DIAORDERS AND PROTECTION OF ORGANS FOR TRANSPLANTATION MITSUI TOATSU CHEMICALS, INC. (JP) 1997-05-06 US disclosed
EP-0726254-A1 Quinoline-4-carbonylguanidine derivates, process for producing the same and pharmaceutical preparations containing the compounds MITSUI TOATSU CHEMICALS, Inc. (JP) 1996-08-14 EP disclosed
US-4711890-A TREATMENT OF ANXIETY STATES OR OF PULMONARY, RENAL, CIRCULATORY OF CARDIOVASCULAR DISORDERS RHONE-POULENC SANTE (FR) 1987-12-08 US disclosed
US-4684652-A TREATING ANXIETY OR CARDIOVASCULAR DISORDERS RHONE-POULENC SANTE (FR) 1987-08-04 US disclosed